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L-Alanine: 4,5-dioxovalerate transaminase was detected in the kidney cytosolic fraction with a lower specific 
activity than the mitochondrial enzyme. The enzyme was purified from the cytosol to homogeneity with a yield 
of 32%, and comparative analysis with the mitochondrial form was performed. Both forms of the enzyme have 
identical pH and temperature optima and also share common antigenic determinants. However, differences in 
their molecular properties exist. The molecular mass of the native cytoplasmic enzyme is 260 kDa, whereas that 
of the mitochondrial enzyme is 210 kDa. In addition, the cytoplasmic L-alanine: 4,5-dioxovalerate transaminase 
had a homopolymeric subunit molecular mass of 67 kDa compared to a subunit molecular mass of 50 kDa for 
the mitochondrial L-alanine: 4,5-dioxovalerate transaminase. This is the first report of two forms of L-alanine: 43-  
dioxovalerate transaminase. The different responses of cytosolic and mitochondrial L-alanine: 4,5-dioxovalerate 
transaminases to hemin supplementation both in vitro and in viva was demonstrated. Maximum inhibition of 
mitochondrial L-alanine: 4,5-dioxovalerate transaminase activity was demonstrated with hemin injected at a dose 
of 1.2 mg/kg body mass, whereas the same dose of hemin stimulated the cytosolic enzyme to 150% of the control. 
A one-dimensional peptide map of partially digested cytosolic and mitochondrial L-alanine: 4,5-dioxovalerate 
transaminase shows that the two forms of the enzymes are structurally related. Partial digestion of the cytosolic 
form of the enzyme with papain generated a fragment of 50 kDa which was identical to that of the undigested 
mitochondrial form (50 kDa). Moreover, papain digestion resulted in a threefold increase in cytosolic enzyme 
activity over the native enzyme, and such enhancement was comparable to the activity of the mitochondrial form 
of the enzyme. Therefore, we conclude that the cytosolic form of L-alanine: 4,5-dioxovalerate transaminase is 
different from the mitochondrial enzyme. 
Furthermore, immunoblot analysis indicated that the mitochondrial enzyme has antigenic similarity to the 
cytosolic enzyme as well as to the papain-digested cytosolic enzyme 50-kDa fragment. 
It is well established that 6-aminolevulinate, the first com- 
mitted precursor of heme, is synthesized by two different 
enzymes, 6-aminolevulinate synthetase and L-alanine : 4,5- 
dioxovalerate transaminase. The synthesis of &amino- 
levulinate is the step at which overall regulation of heme 
biosynthesis occurs [l]. Varticovski et al. [2] and Noguchi and 
Mori [3] have purified L-alanine: 4,5-dioxovalerate transamin- 
ase from bovine liver. In  our laboratory the enzyme has been 
purified from rat liver and kidney mitochondria [4 - 61. 
Morton et al. [7] demonstrated that respiring rat hepatocytes 
can incorporate radioactive 4,5-dioxovalerate into heme, 
thereby suggesting that L-alanine: 4,5-dioxovalerate transam- 
inase takes part in the synthesis of 6-aminolevulinate under 
normal physiological condition. Discovery of 4-0x0-5- 
hydroxyvalerate dehydrogenase [8] which synthesizes 4,5- 
dioxovaleric acid, further supports the concept of an ad- 
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Enzymes. ~-Alanine:4,5-dioxovalerate transaminase (EC 
2.6.1.43); 6-aminolevulinate synthetase (EC 2.3.1.37); glutamate de- 
hydrogenase (EC 1.4.1.3); 6-aminolevulinate dehydratase (EC 
4.4.1.24); catalase (EC 1.11.1.6); papain (EC 3.4.22.2); chymotrypsin 
(EC 3.4.21.1). 
ditional route of 6-aminolevulinate synthesis operating in 
mammalian-heme biosynthesis. In light of the discovery of 
an alternative route of 6-aminolevulinate synthesis, it be- 
came necessary to study the regulatory role of L-alanine : 4,5- 
dioxovalerate transaminase in heme biosynthesis. It has been 
shown that L-alanine: 4,5-dioxovalerate transaminase is in- 
hibited in vitro as well as in vivo by administration of hemin 
[6, 91. This enzyme is induced by phenylhydrazine and it was 
observed that the level of enzyme in the system was inversely 
related to the level of the heme pool [lo], thus suggesting that 
L-alanine : 4,5-dioxovalerate transaminase is under feedback 
control of the intracellular heme pool. 
L-Alanine:4,5-dioxovalerate transaminase from bovine 
liver [3], rat liver and kidney [4, 61 has been shown to be 
present predominantly in mitochondria. It is known that most 
of the mitochondrial enzymes encoded by nuclear genes are 
translated in the cytoplasm as larger precursors [ll - 151 which 
are subsequently processed into smaller mature forms during 
translocation across the mitochondrial membranes. There- 
fore, it is of interest to examine whether mitochondrial L- 
alanine :4,5-dioxovalerate transaminase is the mature product 
of a larger precursor synthesised in the cytosol, or a form 
different from mitochondrial enzyme. 
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MATERIALS AND METHODS 
Materials 
Male Wistar rats (150-175 g) were obtained from 
Haryana Agriculture University (Hissar, India). Sucrose (su- 
crose density grade), L-alanine, 6-aminolevulinate and hemin 
were from Sigma Chemical Co. (St Louis, MO); phenyl- 
Sepharose CL-4B, aminohexyl - Sepharose-4B, Sepharose 
6B, the gel-filtration kit and molecular-mass-marker-protein 
kit were obtained from Pharmacia Fine Chemicals AB 
(Uppsala, Sweden). DEAE-cellulose DE-52 was purchased 
from Whatman (England); acrylamide and Coomassie 
brilliant blue R-250 were obtained from Bio-Rad (Richmond, 
California); 3,5-dibromolevulinic acid was bought from Por- 
phyrin Products (Logan, Utah). Papain and chymotrypsin 
were obtained from SRL (India). 
Methods 
4,5-Dioxovalerate was prepared from 3,5-dibromo- 
levulinic acid as described by Varticovski et al. [2]. 
Preparation of organelles. Organelle separation was carried 
out according to the procedure described by Noguchi and 
Mori [3] with minor modification. Rat kidney was 
homogenized with 4 vol. 0.25 M sucrose in 5 mM potassium 
phosphate buffer, pH 7.6, and centrifuged at 500 g for 10 min. 
1.5 ml rat-kidney postnuclear fraction was loaded onto a lin- 
ear sucrose density gradient (20 - %%, mass/vol.) in 36 ml 
5 mM potassium phosphate buffer, pH 7.6, and centrifuged 
at 60000 g for 4 h in a swinging-bucket rotor (SW 41) in a 
Beckman ultracentrifuge. Fractions (2 ml) were collected from 
the bottom of the tube. The fractions were marked as mito- 
chondrial, cytosolic and peroxisomal by the marker enzymes 
glutamate dehydrogenase, 6-aminolevulinate dehydratase, 
and catalase, respectively. L-Alanine: 4,5-dioxovalerate trans- 
aminase was assayed in all fractions. 
Hemin treatment. Male Wistar rats (80 - 100 g) were inject- 
ed with hemin. Hemin was prepared as described previously 
[16] and injected into the tail vein within 1 h of preparation. 
30 min after injection the animals were killed by decapitation. 
Enzyme assays. L-Alanine: 4,5-dioxovalerate transaminase 
was assayed according to Varticovski et al. [2] with minor 
modification. The assay system used to measure the formation 
of 6-aminolevulinic acid contained 1 mM dioxovalerate, 
20 mM L-alanine, 50 mM potassium phosphate buffer, 
pH 6.9, enzyme and distilled water to a final reaction volume 
of 1 .O ml. Incubation was carried out at 65 "C for 30 min since 
the optimum temperature of this enzyme was reported earlier 
[5, 61 to be 6 5 T .  The reaction was stopped by the addition 
of 0.2 ml25% trichloroacetic acid. h-Aminolevulinic acid was 
converted to 2-methyl-3-carbethoxy-4-(3-propionyl)pyrrole 
by the method of Mauzerall and Granick [I71 and the Ehrlich 
chromophore was measured at  553 nm. Glutamate dehydro- 
genase was assayed as described by King [18]. &Amino- 
levulinate dehydratase and catalase were assayed by the 
method of Anderson and Desnick [I91 and Aebi [20], respec- 
tively. One unit (1 U) L-alanine : 4,5-dioxovalerate transamin- 
ase is defined as the amount of enzyme catalyzing the forma- 
tion of l pmol 6-aminolevulinic acid . mg protein-' 
. 30 min-' at  65°C. 
Electrophoresis. The purity of the protein was checked by 
SDS/PAGE performed according to Laemmli [ZI]. Protein 
was assayed by Lowry's method [22]. 
Papain digestion of cytosolic and mitochondria1 L-alanine: 
4,5-dioxovaleric acid transaniinase. 15 pg cytosolic L-ala- 
nine: 4,5-dioxovalerate transaminase was digested with 0.1, 
0.5 and 1 pg papain for 10 min in 0.05 M Tris buffer, pH 8.0, 
containing 0.05 M cysteine and 0.02 M EDTA at 30°C. After 
digestion was complete, the samples were divided into two 
parts. To one part, Laemmli SDSjPAGE sample buffer was 
added and the mixture was boiled at 100°C. The remaining 
sample was used for enzyme assay. 
One-dimensional peptide map. 7-pg aliquots of both the 
cytosolic and mitochondrial L-alanine:4,5-dioxovalerate 
transaminase were treated with 0.1 pg and 0.25 pg 
chymotrypsin in 0.125 M Tris buffer, pH 6.8, at 30°C for 
10min. At the end of the incubation, the digestion was 
stopped by the addition of Laemmli SDSjPAGE sample 
buffer followed by boiling at 100°C. The samples were electro- 
phoresed by 15% SDSjPAGE. Peptide fragments were detect- 
ed by the silver staining method [23]. 
Antisera preparation. Purified L-alanine : 4,5-dioxovalerate 
transaminase (0.5 - 1 mg) was emulsified with 1 vol. Freund's 
complete adjuvant and injected subcutaneously at multiple 
sites on the back of a New-Zealand white rabbit. A booster 
injection of 200 pg was administered after 14-20 days. The 
rabbit. was bled 10 days later and the antiserum separated. 
Antibody was detected by Ouchterlony double immunodif- 
fusion [24]. 
Western-blot analysis. Electrotransfer of protein from a 
12.5% SDS/polyacrylamide gel was according to the method 
of Towbin [25]. Immunodetection of the transferred protein 
was performed using a Promega Protblot Western-blot AP 
system. 
RESULTS 
Subcellular localization 
of L-alanine: 4,5-dioxovalerate transaminase 
A representative sedimentation in sucrose density gradient 
of the homogenate from rat kidney is presented in Fig. 1. The 
peroxisomes, mitochondria and cytosol were sedimented at a 
density of about 1.23, 1.21 and 1.09 gjml, respectively. Fig. 1 
shows the subcellular distribution of ~-alanine:4,5-dioxo- 
valerate transaminase and also the activity of the marker 
enzymes catalase, glutamate dehydrogenase and 6-aminolevu- 
linate dehydratase in the sucrose density fractions of the post- 
nuclear rat-kidney homogenate fraction. Kidney L-ala- 
nine:4,5-dioxovalerate transaminase was assayed at 65 "C, 
which was found to be the optimum temperature [6]. The L- 
alanine: 4,5-dioxovalerate transaminase activity profile shows 
a major peak overlapping that of glutamate dehydrogenase 
and a minor peak coinciding with that of 6-aminolevulinate 
dehydratase, the cytoplasmic marker. Glutamate dehydroge- 
nase activity was not detectable in the cytosolic fractions. L- 
Alanine: 4,5-dioxovalerate transaminase activity was not de- 
tected in the cytoplasmic fraction when assayed at 37°C. 
Pur iji'cat ion 
of cytosolic L-alanine: 4,5-dioxovalerate transaminase 
All purification procedures were carried out at 4°C unless 
stated otherwise. The results of the enzyme purification are 
summarized in Table 1. 
Fractionation of cytoplasmic extract by heat treatment. The 
postnuclear fraction of kidney homogenate in 0.25 M sucrose, 
10 mM potassium phosphate buffer was centrifuged at 
10000 g for 20 min and the supernatant further centrifuged at 
60000 g for 4 h. After discarding the pellet, the supernatant 
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Fig. 1. Subcellular distribution of ~-alanine:4,5-dioxovabrate transarninase in rat kidney. The kidney postnuclear supernatant was subjected to 
sucrose dcnsity gradient as described in Materials and Methods. Glutamate dehydrogenase (0 ) ;  6-aminolevulinate dehydratasc (a); catalase 
(A) ;  L-alanine:4,5-dioxovalerate transaminase (0). ALA, 6-aminolevulinate 
Table 1. Purification of ~-alanine:4,5-dioxovalerate transaminase,from rat kidney cytosol 
Purification step L-Alanine: 4,5-dioxovalerate transaminase 
protein total activity specific activity purification yield 
mg U U/mg protein -fold % 
Cytosol 268 6.16 0.023 1 .o 100 
Heat treatment 203 5.40 0.027 1.1 87.6 
Phenyl-Sepharose 24 3.20 0.13 5.7 51.9 
Sepharose 6B 18 3.01 0.17 7.2 49.0 
Ion exchange 8 2.31 0.29 12.5 37.0 
Affinity 0.3 2.0 6.67 290 32.0 
was heated at 60°C for 5 min. The precipitate was removed 
by centrifugation at  10000 g for 20 min. 
P h e n y l ~  Sepharose-CL-4B column chromatography. The 
supernatant obtained from the above was applied to a column 
of phenyl - Sepharose-CL-4B (2.9 cm x 11 cm) using 5 mM 
potassium phosphate buffer, pH 7.6. The enzyme did not bind 
to the hydrophobic support and was eluted in buffer. The 
fractions with high activity were pooled and concentrated 
using poly(ethy1ene glycol) 20000. 
Sepharose 6 B  column chromatography. The concentrated 
sample (4ml) was loaded on to a Sepharose 6B column 
(2.5 cm x 42 cm) and eluted with 5 mM potassium phosphate 
buffer, pH 7.6. The flow rate was 16 rnljh. 
DEAE-cellulose DE-52 column chromatography. The active 
fractions from the previous column were pooled and loaded 
on to a DEAE-cellulose DE-52 column (2.75 cm x 19 cm), 
equilibrated with the same buffer. The enzyme was eluted with 
a 0-0.5 M KC1 gradient, total volume 500 mi, at  a flow rate 
of 20 ml/h. The enzyme eluted approximately in the middle of 
the gradient. 
L-Alanine - Sepharose-4B column chromatography. The 
pooled fraction from DEAE-cellulose DE-52 was applied fi- 
nally to an L-alanine - Sepharose-4B column (1.32 cm 
x 4.0 cm), which was equilibrated with 5 mM potassium 
phosphate buffer, pH 7.6, containing 10% glycerol. The 
column was washed first with 400 ml of the same buffer, then 
the enzyme was eluted with a 0-0.4 M KCl linear gradient 
of total volume 200ml in the same buffer at a flow rate 
of 20 ml/h (Fig. 2). The fractions exhibiting ~-alanine:4,5- 
dioxovalerate transaminase were pooled and concentrated 
using an Amicon ultrafiltration cone, dialyzed against 5 mM 
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Fig. 2. L-Alanine - Sepharose-4B affinity chromatography of rat kidney 
cytosolic ~-alanine:4,5-dioxovalerate transaminase. The pooled en- 
zyme fraction was applied to the affinity column (1.32 cm x 4 cm), 
washed with 5 mM potassium phosphate buffer, pH 7.6 and a linear 
KCl gradient (0-0.4 M KCl, 200 mi) applied at a flow rate of 20 ml/ 
h. (0) Absorbance at 280 nm; (0 )  ~-alanine:4,5-dioxovalerate trans- 
aminase activity. Fractions of 4 ml were collected 
potassium phosphate buffer, pH 7.6, containing 10% glycerol, 
then stored at  -20°C. 
The purity of the enzyme was checked and appeared to be 
homogeneous, yielding a single band in SDSjPAGE at pH 8.9 
(Fig. 3). 
Optimal conditions 
The cytoplasmic L-alanine: 4,5-dioxovalerate transamin- 
ase was shown to have a pH optimum of 6.6 and a temperature 
optimum of 65 "C. 
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3 Table 2. Effect of hemin on the purfied cytosolic and mitochondria( L- 
alunine: 4,5-dioxovalerate transaminase 
Partially pure ~-alanine:4,5-dioxovalerate transaminase, having a 
specific activity of 0.2 U/mg, was incubated with varying concen- 
trations of hemin at  room temperature. The reaction was started by 
addition of substrates and incubation at  65 "C for 30 min. The product 
formed was estimated as described in Materials and Methods 
Hemin Specific activity of 
concentration alanine:4,5-dioxo- 
valerate transaminase 
Fig. 3. SDSjPAGE of purified rut-kidney cytosolic and mitochondrial 
L-alanine: 4,5-dioxovalerate transaminase under denaturing conditions. 
10 pg of the standard marker proteins, phosphorylase b (94 kDa), 
albumin (67 kDa), ovalbumin (43 kDa), carbonic anhydrase 
(30 kDa), trypsin inhibitor (20 kDa) and lactalbumin (14.4 kDa) and 
4 pg purified samples were electrophoresed simultaneously. Calcu- 
lation of the mobilities of the marker proteins as well as that of the 
samples are expressed relative to the bromophenol-blue dye front. 
The protein bands were detected by the silver staining method. Lane 
1,  marker proteins; lane 2, cytosolic ~-alanine:4,5-dioxovalerate 
transaminase; lane 3, mitochondrial ~-alanine:4,5-dioxovalerate 
transaminase 
Fig. 4. Compurison i 
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the molecular musses of cylosolic and mitochon- 
drial r-ulanine:4,5-dioxovalerute transaminase on a Sephurose 6 B  
column (2.5 cm x 42 cm). The column was calibrated with 1 mg ferri- 
tin (440 kDa), 2 mg thyroglobulin (669 kDa), 2 mg aldolase 
(158 kDa) and 5 mg catalase (232 kDa). ( 0 )  Mitochondrial; (0) 
cytosolic 
Comparison of native andsubunit molecular masses of cytosolic 
and mitochondrial L-alanine: 4,5-dioxovalerate transaminase 
When 0.5 mg each of native cytosolic and mitochondrial 
L-alanine: 4,5-dioxovalerate transaminase were run separately 
on a Sepharose-6B gel-filtration column, elution volumes of 
132 ml and 148 ml, corresponding to molecular masses of 
260 kDa and 210 kDa, respectively, were obtained for 
cytosolic and mitochondria1 L-alanine:4,5-dioxovalerate 
transaminase (Fig. 4), indicating that they are different forms 
of the same enzyme. 
When cytosolic and mitochondrial L-alanine: 4,Sdioxo- 
valerate transaminases were subjected to denaturing SDS/ 
PAGE the cytosolic form showed a subunit molecular mass 
of 67 kDa, but a subunit molecular mass of 50 kDa was 
obtained for mitochondrial L-alanine: 4,5-dioxovalerate trans- 
aminase (Fig. 3). 
cytosol mitochondria 
PM U/mg ("/.I 
0 
to  
25 
50 
0.2 (100) 1.2 (100) 
0.2 (100) 1 .o (83) 
0.2 (100) 0.8 (66) 
0.15 (75) 0.5 (41) 
Differences in the responses of cytosolic 
and mitochondria1 L-alanine: 4,5-dioxovalerate transaminase 
to hemin in vitro and in vivo 
Purified cytosolic and mitochondrial L-alanine: 4 3 -  
dioxovalerate transaminases were incubated in vitro with 
hemin at  concentrations from 10-50 pM. It was observed 
that cytosolic and mitochondrial enzymes were inhibited by 
hemin to different extents. At 50 pM, the maximum concen- 
tration used, the cytosolic enzyme still retained 75% of the 
control activity, whereas the mitochondrial enzyme a t  the 
same concentration of hemin had only 41% of the control 
activity (Table 2). 
Since in vitro incubation of the cytosolic enzyme with 
hemin had little effect, we further examined the possibility of 
a regulatory effect of hemin on the cytosolic ~-alanine:4,5- 
dioxovalerate transaminase. Rats were administered hemin 
(0.8 - 2.0 mg/kg body mass) intravenously and sacrificed after 
30 min. The activities of cytosolic and mitochondrial L-ala- 
nine:4,5-dioxovalerate transaminases were assayed. It was ob- 
served that up to a hemin dose of 1.2 mg/kg body mass, the 
mitochondrial enzyme activity decreased progressively with a 
concomitant increase in the activity of the cytosolic enzyme 
to 150% of the control. However, at a higher dose of hemin 
(2.0 mg/kg body mass) the activities of both the cytosolic 
and the mitochondrial enzymes were inhibited (Fig. 5). When 
enzyme activity in the post nuclear Fraction was assayed, there 
was no apparent change in the total enzyme activity. The 
results suggest that hemin a t  the dose employed (0.8 - 1.2 mg/ 
kg body mass) interferes only with the mitochondrial L-ala- 
nine:4,5-dioxovalerate transaminase activity, while the 
cytosolic enzyme remained uninhibited, thus supporting the 
hypothesis that hemin does not inhibit the cytosolic ~ - a l a -  
nine: 4,5-dioxovalerate transaminase in vitro to the same ex- 
tent. 
One-dimensional peptide map of cytosolic 
and mitochondria1 L-alanine: 4,5-dioxovalerate transaminase 
In order to examine the structural relationship of cytosolic 
and mitochondrial L-alanine: 4,5-dioxovalerate transaminase, 
each of the purified enzymes was digested with 0.1 pg and 
0.25 pg chymotrypsin for 10 min at  30°C. At the end of 
10 min, the digestion was stopped and the samples were run 
on 15% SDSjPAGE (Fig. 6). Cytosolic ~-alanine:4,5- 
2 3 L 
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Fig. 5. Effect of hemin treatment on rat kidney i.-alanine:4,5- 
dioxovalerate transaminase. Different doses of hemin were injected 
intravenously (as described in Materials and Methods) and the ani- 
mals were killed 30 min after injection. ~-Alanine:4,5-dioxovalerate 
transaminase activity is expressed as a percentage of the specific 
activity of thc control. DOVA; dioxovalcrate 
1 2 3 L kDa 
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Fig. 6.One-dimen,sionulpeptide map ofpurified cytosolic andmitochon- 
drial L-alanine:4,5-dioxovalerate transaminuses. Pure cytosolic and 
mitochondrial enzyme, 7.0 pg each, were digested with 0.1 pg and 
0.25 pg chymotrypsin for 10 min at  30°C. The digestion was stopped 
and samples were run in 15% SDS/PAGE. Lanes 1 and 4 represent 
cytoplasmic ~-alanine:4,5-dioxovalerate transaminase digested with 
0.1 pg and 0.25 pg chymotrypsin and lanes 2 and 3 represent mito- 
chondrial r,-alanine:4,5-dioxovalerate transaminase digested with 
0.1 pg and 0.25 pgchymotrypsin, respectively. The protein bands were 
detected with silver staining 
dioxovalerate transaminase, digested with 0.1 pg chymo- 
trypsin (lane l), yielded peptide fragments of 50, 40, 36, 30 
and 28 kDa, of which the fragments (50 kDa) generated from 
the cytosolic enzyme were identical to the uncut mitochondrial 
form of the enzyme. In addition, a fragment of 40 kDa was 
kDa 1 
67 - 
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30- 
20- 
1L.L - 
Fig. I .  Partial digestion of cytosolic L-alanine: 4.5-dio.xovalerate trans- 
aminase with papain. Lane 1, standard molecular mass marker pro- 
teins; lane 2, undigested cytosolic enzyme; lanes 3 - 5, cytosolic en- 
zyme digested with 0.1, 0.25 and 0.5 pg chymotrypsin; lane 6. 
undigested mitochondrial enzyme. The bands were detected by silver 
staining. 
observed for both cytosolic (Fig. 6, lane 1) and mitochondrial 
(lane 2) ~-alanine:4,5-dioxovalerate transaminase digested 
with 0.1 pg chymotrypsin. Moreover the mitochondrial en- 
zyme, upon digestion with 0.1 pg chymotrypsin generated a 
fragment 36 kDa (Fig. 6, lane 2) which was absent when the 
cytosolic enzyme was digested with chymotrypsin at the same 
concentration (lane 1). However, this fragment appeared when 
the cytosolic enzyme was digested with 0.25 pg chymotrypsin 
(Fig. 6, lane 4). On the contrary, the fragments of 30 kDa and 
28 kDa obtained after digestion of the cytosolic enzyme with 
0.1 pg (Fig. 6, lane 1) and 0.25 pg chymotrypsin (lane 4) were 
never observed as mitochondrial digestion products (lanes 2 
and 3). Our observations suggests that cytosolic and mito- 
chondrial enzymes share structural similarities while at  the 
same time they differ to a certain extent. 
Increased activity of cytosolic L-alunine: 4,5-dioxovalerate 
transaminuse by papain digestion 
Cytosolic ~-alanine:4,5-dioxovalerate transaminase 
(20 pg) was digested with 0.1,0.25 and 0.5 pg papain at 37 "C 
for 10 min. Part of each digestion mixture was subjected to 
15% denaturing SDSjPAGE along with the undigested 
cytosolic and mitochondrial forms of the enzyme. The rest of 
the digestion mixture was assayed for enzyme activity. Fig. 7 
shows the results of papain digestion. During digestion of 
cytosolic L-alanine:4,5-dioxovalerate transaminase, a frag- 
ment having the same molecular mass (50 kDa) as that of 
the uncut mitochondrial form (Fig. 7, lane 6) was generated 
progressively as the concentration of papain increased over 
0.1 -0.5 pg (lanes 2-4). The progressive generation of the 
50 kDa band was accompanied by a gradual increase in en- 
zyme activity (Table 3). Table 3 shows that the native cytosolic 
enzyme has a specific activity of 0.43 U/mg protein, which is 
less than that of the mitochondrial form. Digestion with 
papain (0.5 pg) not only generated the identical subunit of 
50 kDa, but also increased the enzyme activity almost three- 
fold. This observation shows that proteolytic hydrolysis of the 
cytosolic enzyme generates an enzymatically more active form. 
Immunological cross-reactivity of the mitochondria1 enzyme 
with the cytosolic form and its proteolytic frugment 
with an antibody raised against the mitochondria1 enzyme 
In order to examine the cross-reactivity of the cytosolic 
L-alanine: 4,5-dioxovalerate transaminase and its proteolytic 
fragments with antiserum against the mitochondrial enzyme, 
cytoplasmic L-alanine: 4,5-dioxovalerate transaminase (1 0 pg) 
was digested with increasing concentrations (3 pg and 6 pg) 
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Table 3. Eflect of papain treatment on the activity of cytosolic L-ah- 
nine : 4,s-ciioxovalerate transaminuse 
Purified ~-alanine:4,5-dioxovalerate transaminase (specific activity 
0.43 Ujmg) was incubated a t  37°C with varying concentrations of 
papain for 10 min. After 10 min incubation, the reaction was started 
by the addition of substrates and incubation at  65°C for 30 min. The 
product formed was estimated as in Materials and Methods. The 
specific activity of the mitochondrial enzyme was 31.5 U/mg 
Papain L-Alanine: 4,s-dioxovalerate 
concentration transaminase specific activity 
kg 
0 
0.1 
0.25 
0.5 
U . mg protein-' . 30 min-' 
0.43 
0.67 
0.81 
1.30 
1 2  3 1 5 kDa 
- 91 
- 67 
- 13 
- 30 
Fig. 8. Immunohlot analysis of papain-digested cytosolic L-alanine:4,5- 
dioxovalerate transaminase using an antibody against the mitochondrial 
enzyme. 10 pg cytosolic alanine:4,5-dioxovalerate transaminase was 
digested with papain, transferred on to nitrocellulose and the blot 
incubated with anti-(mitochondria1 ~-alanine:4,5-dioxovalerate 
transaminase) antibody. Lane 1, cytosolic enzyme; lane 2, cytosolic 
enzyme digested with 3 pg papain; lane 3, cytosolic enzyme digested 
with 6 pg papain; lane 4, mitochondrial ~-alanine:4,5-dioxovalerate 
transaminase; lane 5 ,  molecular mass marker proteins stained with 
0.2% amido black 
of papain for 10 min and electrophoresed simultaneously with 
undigested cytosolic and mitochondrial L-alanine: 4 3 -  
dioxovalerate transaminase in a 12.5 YO SDS/polyacrylamide 
denaturing gel. Electrophoresis was followed by electro- 
blotting on nitrocellulose paper. 
The nitrocellulose was then incubated with antibody 
(1 : 2000 dilution) raised against mitochondrial L-alanine : 4 3 -  
dioxovalerate transaminase. Fig. 8 shows that cytosolic L- 
alanine : 4,s-dioxovalerate transaminase, as well as the frag- 
ments generated by digestion with papain, cross-react with 
antibody raised against the mitochondrial form of the enzyme. 
During partial digestion of the cytosolic L-alanine: 4 3 -  
dioxovalerate transaminase with lower concentrations of 
papain, it was apparent that digested fragments were equally 
cross-reactive with the antibody raised against the mitochon- 
drial enzyme as well as with the 67 kDa fragment of the 
cytosolic enzyme. The results demonstrate an  immunological 
relationship between the cytosolic and mitochondrial L-ala- 
nine: 4,5-dioxovalerate transaminase. 
DISCUSSION 
The present study reports the occurrence and purification 
of the cytoplasmic form of L-alanine: 4,5-dioxovalerate trans- 
aminase in addition to our earlier report on the purification of 
mitochondrial L-alanine : 4,s-dioxovalerate transaminase [4 - 
61. Since no glutamate dehydrogenase activity was detectable 
in the cytosolic fraction, the possibility of mitochondrial L- 
alanine : 4,5-dioxovalerate transaminase leaching out into the 
cytosol is ruled out. Therefore, the enzyme activity detected 
may be exclusively due to a cytosolic form of ~-alanine:4,5- 
dioxovalerate transaminase. It is important to mention here 
that the cytosolic enzyme has a lower specific activity than 
the mitochondrial enzyme. Furthermore, in this paper we 
described a procedure for purification of the cytosolic enzyme 
using L-alanine - Sepharose-4B affinity chromatography. We 
compared the molecular properties of the cytosolic and mito- 
chondrial enzymes and it is evident that the cytosolic enzyme 
is the high-molecular-mass protein of 260 kDa. Both enzymes 
are homotetramers. The cytosolic enzyme has a higher subunit 
molecular mass (67 kDa) than the mitochondrial enzyme 
which has a subunit molecular mass of 50 kDa. However, they 
have common antigenic site(s) and their temperature and pH 
optima are identical. Differences in the molecular properties 
of L-alanine: 4,5-dioxovalerdte transaminase purified from the 
cytosol and from mitochondria are also supported by differ- 
ences in the inhibitory effect of hemin in vitro on the activity 
of the enzymes. Incubation of hemin with purified enzyme has 
little inhibitory effect on the cytosolic enzyme. The mitochon- 
drial form of the enzyme can be inhibited with hemin at a 
concentration as low as 10 pM and 60% inhibition was ob- 
served with 50 pM hemin (Table 2). In contrast, the cytosolic 
form of the enzyme remained fully active with hemin up to a 
concentration of 25 pM. However, a dose of SO pM hemin 
produces only 25% inhibition. 
The different nature of the mitochondrial and cytoplasmic 
enzymes is further elaborated by different responses to hemin 
injection. As reported earlier, hemin injection inhibits the ac- 
tivity of mitochondrial L-alanine: 4,5-dioxovalerate transam- 
inase. Inhibition (60%) of the activity of mitochondrial L- 
alanine: 4,5-dioxovalerate transaminase is obtained with 0.8 - 
1.2 mg/kg body mass of hemin, whereas 150% stimulation in 
the activity of the cytoplasmic form of ~-alanine:4,5- 
dioxovalerate transaminase is observed. Stimulation of 
cytosolic L-alanine: 4,s-dioxovalerate transaminase and inhi- 
bition of the mitochondrial enzyme by intravenous hemin 
injection clearly shows that both forms of the enzyme are 
different. However, our result for the in vivo experiment is in 
agreement with our in vitro observation that the mitochondrial 
form is inhibited by hemin at  lower doses than the cytosolic 
enzyme. Cytosolic L-alanine : 4,5-dioxovalerate transaminase 
has a lower specific activity as compared to the mitochondrial 
enzyme. Therefore, in order to examine whether proteolytic 
digestion of the enzyme generates forms of higher activity, we 
digested the cytosolic form with increasing concentrations 
of papain at  30°C for 10 min. It was observed that as the 
concentration of papain increases, a peptide fragment from 
the cytosolic enzyme with the same subunit molecular mass 
(50 kDa) as the native mitochondrial form, is generated. Fur- 
thermore, by assaying the activity of the papain-digested 
cytosolic enzyme, it was shown that the appearance of the 
50 kDa fragments was accompanied by an almost threefold 
increase in the activity of the cytosolic L-alanine: 4,5- 
dioxovalerate transaminase. Conversion of the cytosolic low 
activity form to a high activity one may be due to a change in 
the conformation due to papain digestion. The appearance of 
the 50-kDa fragment during papain digestion of the cytosolic 
form and its immunological cross-reactivity with antibody 
raised against the mitochondrial enzyme, suggest that both 
mitochondrial and cytosolic ~-alanine:4,5-dioxovalerate 
transaminases share a common fragment with a molecular 
mass of 50 kDa. 
However, the cytosolic and mitochondrial L-alanine: 43- 
dioxovalerate transaminases, digested with 0.1 pg and 0.25 pg 
chymotrypsin not only generate identical fragments of 50 kDa 
and 40 kDa, but also give rise to 30 kDa and 28 kDa frag- 
ments which are not observed as digestion products of the 
mitochondrial form at the concentrations of chymotrypsin 
used. However, a 36-kDa mitochondrial digest product 
(Fig. 7, lane 2), although missing from cytosolic enzyme digest 
with 0.1 pg chymotrypsin (Fig. 7, lane l), appeared later upon 
digestion with 0.25 pg chymotrypsin (lane 4). The one-dimen- 
sional peptide map shows that although both forms share 
some common fragments, differences in molecular properties 
exist between the two forms. Our present study shows that 
mitochondrial and cytosolic ~-alanine:4,5-dioxovalerate 
transaminases, although possessing some structural similari- 
ties, are basically different forms. 
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